Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chronic obstructive pulmonary disease--an independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease.
Nishiyama K, Morimoto T, Furukawa Y, Nakagawa Y, Ehara N, Taniguchi R, Ozasa N, Saito N, Hoshino K, Touma M, Tamura T, Haruna Y, Shizuta S, Doi T, Fukushima M, Kita T, Kimura T. Nishiyama K, et al. Among authors: hoshino k. Int J Cardiol. 2010 Aug 20;143(2):178-83. doi: 10.1016/j.ijcard.2009.02.010. Epub 2009 Apr 14. Int J Cardiol. 2010. PMID: 19368979 Free article.
Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era.
Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, Taniguchi R, Doi T, Nishiyama K, Ozasa N, Saito N, Hoshino K, Mitsuoka H, Abe M, Toma M, Tamura T, Haruna Y, Imai Y, Teramukai S, Fukushima M, Kita T. Kimura T, et al. Among authors: hoshino k. Circulation. 2008 Sep 30;118(14 Suppl):S199-209. doi: 10.1161/CIRCULATIONAHA.107.735902. Circulation. 2008. PMID: 18824755
Coronary risk factor profile and prognostic factors for young Japanese patients undergoing coronary revascularization.
Furukawa Y, Ehara N, Taniguchi R, Haruna Y, Ozasa N, Saito N, Doi T, Hoshino K, Tamura T, Shizuta S, Abe M, Toma M, Morimoto T, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators. Furukawa Y, et al. Among authors: hoshino k. Circ J. 2009 Aug;73(8):1459-65. doi: 10.1253/circj.cj-08-1083. Epub 2009 Jun 16. Circ J. 2009. PMID: 19531902 Free article.
Effect of baseline glycemic level on long-term cardiovascular outcomes after coronary revascularization therapy in patients with type 2 diabetes mellitus treated with hypoglycemic agents.
Ehara N, Morimoto T, Furukawa Y, Shizuta S, Taniguchi R, Nakagawa Y, Hoshino K, Saito N, Doi T, Haruna Y, Ozasa N, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T. Ehara N, et al. Among authors: hoshino k. Am J Cardiol. 2010 Apr 1;105(7):960-6. doi: 10.1016/j.amjcard.2009.11.024. Epub 2010 Feb 13. Am J Cardiol. 2010. PMID: 20346313
Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention.
Abe M, Morimoto T, Akao M, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, Taniguchi R, Doi T, Nishiyama K, Ozasa N, Saito N, Hoshino K, Mitsuoka H, Toma M, Tamura T, Haruna Y, Kita T, Kimura T. Abe M, et al. Among authors: hoshino k. Am J Cardiol. 2014 Aug 1;114(3):362-8. doi: 10.1016/j.amjcard.2014.05.009. Epub 2014 May 16. Am J Cardiol. 2014. PMID: 24927973
Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease: perspectives from the CREDO-Kyoto registry.
Furukawa Y, Taniguchi R, Ehara N, Ozasa N, Haruna Y, Saito N, Doi T, Hoshino K, Shizuta S, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators. Furukawa Y, et al. Among authors: hoshino k. Circ J. 2008 Dec;72(12):1937-45. doi: 10.1253/circj.cj-08-0293. Epub 2008 Oct 24. Circ J. 2008. PMID: 18948669 Free article.
Clopidogrel resistance in Japanese patients scheduled for percutaneous coronary intervention.
Hoshino K, Horiuchi H, Tada T, Tazaki J, Nishi E, Kawato M, Ikeda T, Yamamoto H, Akao M, Furukawa Y, Shizuta S, Toma M, Tamura T, Saito N, Doi T, Ozasa N, Jinnai T, Takahashi K, Watanabe H, Yoshikawa Y, Nishimoto N, Ouchi C, Morimoto T, Kita T, Kimura T. Hoshino K, et al. Circ J. 2009 Feb;73(2):336-42. doi: 10.1253/circj.cj-08-0559. Epub 2008 Dec 24. Circ J. 2009. PMID: 19106460 Free article. Clinical Trial.
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial.
Natsuaki M, Morimoto T, Yamamoto E, Shiomi H, Furukawa Y, Abe M, Nakao K, Ishikawa T, Kawai K, Yunoki K, Shimizu S, Akao M, Miki S, Yamamoto M, Okada H, Hoshino K, Kadota K, Morino Y, Igarashi K, Tanabe K, Kozuma K, Kimura T. Natsuaki M, et al. Among authors: hoshino k. Cardiovasc Interv Ther. 2016 Jul;31(3):196-209. doi: 10.1007/s12928-015-0366-9. Epub 2015 Oct 30. Cardiovasc Interv Ther. 2016. PMID: 26518420 Free PMC article. Clinical Trial.
One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation.
Natsuaki M, Morimoto T, Yamamoto E, Watanabe H, Furukawa Y, Abe M, Nakao K, Ishikawa T, Kawai K, Yunoki K, Shimizu S, Akao M, Miki S, Yamamoto M, Okada H, Hoshino K, Kadota K, Morino Y, Hanaoka KI, Tanabe K, Kozuma K, Kimura T; STOPDAPT trial investigators. Natsuaki M, et al. Among authors: hoshino k. PLoS One. 2020 Mar 25;15(3):e0227612. doi: 10.1371/journal.pone.0227612. eCollection 2020. PLoS One. 2020. PMID: 32210433 Free PMC article. Clinical Trial.
1,128 results